ロード中...
RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in children, yet no vaccine is available. The sole licensed preventive treatment against RSV is composed of a monoclonal neutralizing antibody (palivizumab), which targets a conformational epitope located on the f...
保存先:
| 出版年: | Nanomedicine |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698904/ https://ncbi.nlm.nih.gov/pubmed/27553073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.08.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|